The World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents)

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

• Introduction
• Scope and Methodology
• Size and Growth of the Market
• Issues and Trends Affecting Market
• Leading Competitors

CHAPTER TWO: INTRODUCTION

• Overview of the Cardiovascular System
• Heart
• Circulatory System
• Cardiac Cycle
• Isovolumic Contraction
• Ventricular Ejection
• Isovolumic Relaxation
• Coronary Circulation
• Cardiac Myocytes
• Contraction
• Calcium Role in Contraction
• Relaxation
• Cardiac Energy Metabolism
• Cardiac Output
• Cardiovascular Disorders
• Angina
• Incidence
• Etiology and Pathophysiology
• Risk Factors
• Arrhythmias
• Incidence
• Etiology and Pathophysiology
• Risk Factors
• Atherosclerosis
• Incidence
• Etiology and Pathophysiology
• Risk Factors
• Congestive Heart Failure
• Incidence
• Etiology and Pathophysiology
• Risk Factors
• Coronary Artery Disease
• Incidence
• Etiology and Pathophysiology
• Risk Factors
• Hypertension
• Incidence
• Etiology and Pathophysiology
• Risk Factors
• Myocardial Infarction
• Incidence
• Etiology and Pathophysiology
• Risk Factors
• Effects of Aging
• Demographics
• Disease Management

CHAPTER THREE: ISSUES AND TRENDS

• Obesity Epidemic and Heart Disease
• Statin use
• Inflammation Reduction
• Unique Drug Combinations
• Hormone Therapy and Cardiovascular Disease Risks
• CAD Risk Factor Differences in Sexes
• Women and Heart Disease
• Otc Statins
• Genetic Research and Warfarin Use
• Future Trends in the Pharmaceutical Arena

CHAPTER FOUR: PRESCRIPTION CARDIAC GLYCOSIDE AND IONTROPIC DRUGS

• Overview of Cardiac Glycosides and Inotropic Drugs
• Description of Products
• Market Size and Growth World Market
• Research and Development
• Competitive Analysis

CHAPTER FIVE: PRESCRIPTION ANTIHYPERTENSIVE DRUGS

• Overview
• Description of Products
• ACE Inhibitors
• Angiotensin II Receptor Antagonists
• Adrenergic Blockers
• Beta Blockers
• Recent Additions
• Calcium Channel Blockers
• Combinations
• New Developments
• Market Size and Growth
• World Market
• Research and Development
  • Nebivolol
  • CS- 8663
  • Volibris
  • Atacand Plus
  • Clevidipine
  • Coreg CR Plus ACE Inhibitor
  • Darusentan
• Competitive Analysis

CHAPTER SIX: PRESCRIPTION ANTIARRHYTHMIC DRUGS

• Overview
• Description of Products
  • Class I
  • Class II
  • Class III
• Market Size and Growth
• World Market
• Research and Development
  • Tedasamil (Pulzium)
  • RSD 1235 (vernakalant)
  • Apixaban
  • Bay 59-7939
  • Dronedarone (Multaq)
  • Idraparinux
  • Tecadenoson
• Competitive Analysis

CHAPTER SEVEN: VASODILATOR AND PERIPHERAL VASODILATOR DRUGS

• Overview
• Description of Products
• Coronary Vasodilators
• Natriuretic Peptides
• Peripheral Vasodilators
• Recent Developments
• Market Size and Growth
• World Market
• Research and Development
  • BiDil
  • GeneRx
• Competitive Analysis

CHAPTER EIGHT: PRESCRIPTION ANTIHYPERLIPIDEMIC DRUGS

• Overview
• Description of Products
  • Bile Acid Sequestrants
  • Fibric Acid Derivatives
  • HMG-CoA Reductase Inhibitors (Statins)
  • Nicotinic Acid
• Market Size and Growth
• World Market
• Research and Development
  • LCP-FenoChol
  • Synordia
  • Acomplia
  • Actos
  • MK 0524A, MK0524B
  • Pravastatin and Fenofibrate Combination
  • AGI-`067
  • ABT-335
  • Apo-I Milano (ETC-216)
  • ETC-642
  • FM-VP4
• Competitive Analysis

CHAPTER NINE: PRESCRIPTION BLOOD MODIFIER DRUGS

• Overview
• Description of Products
  • Anticoagulants
  • Antiplatelets
  • Thrombolytics
• New Developments
• Market Size and Growth
• World Market
• Research and Development
  • Arixtra
  • Exanta
  • Cangrelor
  • (Prasugrel) CS-747
  • Integrilin
• Competitive Analysis

CHAPTER TEN: PRESCRIPTION DIURETIC DRUGS

• Overview
• Description of Products
• Carbonic Anhydrase Inhibitors
• Loop
• Potassium-Sparing
• Thiazides
• Market Size and Growth
• World Market
• Research and Development
• Competitive Analysis

CHAPTER ELEVEN: PRESCRIPTION OTHER CARDIOVASCULAR DRUGS

• Overview
• Description of Products
• Market Size and Growth
• World Market
• Research and Development
• Thelin
• Remodulin IV
• Ambrisentan (Letairis)
• Celacade
• Tadalafil
• Tolvaptan
• DITPA
• Competitive Analysis

CHAPTER TWELVE: WORLD MARKET SUMMARY

• Overview
• Total Market Size and Forecast
• Competitor Analysis

CHAPTER THIRTEEN: CORPORATE PROFILES

• Abbott Laboratories
• AStellas Pharma, Inc.
• Astra Zeneca
• Bayer Schering Pharma
• Biovail Corporation
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Daiichi Sankyo Pharmaceuticals
• Eli Lilly and Company
• Genentech, Inc.
• GlaxoSmithKline
• MERCK & COMPANY INC
• Novartis International AG
• Pfizer, Inc.
• Roche
• Sanofi-Aventis
• Takeda Pharmaceuticals
• Emerging Cardiovascular Companies
• Cardiome Pharma Corporation
• Inotek Pharmaceuticals Corporation

APPENDIX: COMPANY DIRECTORY

TABLE OF EXHIBITS

EXECUTIVE SUMMARY

• Table 1-1: Total World Prescription Cardiovascular Drug Market 2004-2011
• Figure 1-1: Total World Prescription Cardiovascular Drug Market 2004-2011
• Table1-2: World Market for Prescription
• Cardiovascular Drugs Revenues and Segments of Participation by Major Areas of Participation 2006
• Figure 1-2: World Market for Prescription Cardiovascular Drugs Revenues and Segments of Participation by Major Areas of Participation 2006

CHAPTER TWO: INTRODUCTION

• Table 2-1: U.S. Prevalence, Incidence and Mortality of Selected Cardiovascular Conditions

CHAPTER FOUR: PRESCRIPTION CARDIAC GLYCOSIDE AND IONTROPIC DRUGS

• Table 4-1: Marketed Cardiac Glycosides and Inotropic Drugs
• Table 4-2: Total World Cardiac Glycoside & Inotropic Drug Market 2004-2011
• Figure 4-1: Total World Cardiac Glycoside & Inotropic Drug Market 2004-2011
• Table 4-3: Cardiac Glycosides and Inotropic Agents in Development
• Table 4-4: Total Global Market for Cardiac Glycoside & Inotropic Drugs, Revenues and Market Share by Supplier 2006
• Figure 4-2: Total Global Market for Cardiac Glycoside & Inotropic Drugs, Market Share by Leading Supplier 2006

CHAPTER FIVE: PRESCRIPTION ANTIHYPERTENSIVE DRUGS

• Table 5-1: Marketed ACE Inhibitors
• Table 5-2: Marketed Angiotensin II Receptor Antagonists
• Table 5-3: Marketed Adrenergic and Beta Blockers
• Table 5-4: Marketed Calcium Channel Blockers
• Table 5-5: Marketed Combination and Other Antihypertensives
• Table 5-6: Total World Prescription Antihypertensive Drug Market 2004-2011
• Figure 5-1: Total World Prescription Antihypertensive Drug Market 2004-2011
• Table 5-6: Total World Prescription Antihypertensive Drug Market by Type 2004-2011
• Figure 5-2: Total World Prescription Antihypertensive Drug Market by Type 2006
• Table 5-7: Hypertensive Drugs in Development
• Table 5-8: Total Global Market for Prescription Antihypertensive Drugs, Revenues and Market Share by Supplier 2006
• Figure 5-9: Total Global Market for Prescription Antihypertensive Drugs, Market Share by Leading Supplier 2006

CHAPTER SIX: PRESCRIPTION ANTIARRHYTHMIC DRUGS

• Table 6-1: Marketed Antiarrhythmic Drugs
• Table 6-2: Total World Prescription Antiarrhythmic Drug Market 2004-2011
• Figure 6-1: Total World Prescription Antiarrhythmic Drug Market 2004-2011
• Table 6-3: Antiarrhythmic Drugs in Development
• Table 6-4: Total Global Market for Prescription Antiarrhythmic Drugs, Revenues and Market Share by Supplier 2006
• Figure 6-3: Total Global Market for Prescription Antiarrhythmic Drugs, Market Share by Leading Supplier 2006

CHAPTER SEVEN: VASODILATOR AND PERIPHERAL VASODILATOR DRUGS

• Table 7-1: Marketed Vasodilator and Peripheral Vasodilator Drugs
• Table 7-2: Total World Vasodilator and Peripheral Vasodilator Drugs Market 2004-2011
• Figure 7-2: Total World Vasodilator and Peripheral Vasodilator Drugs Market 2004-2011
• Table 7-3: Vasodilator and Peripheral Vasodilator Drugs in Development
• Table 7-4: Total Global Market for Vasodilator and Peripheral Vasodilator Drugs Revenues and Market Share by Supplier 2006
• Figure 7-4: Total Global Market for Vasodilator and Peripheral Vasodilator Drugs Market Share by Leading Supplier 2006

CHAPTER EIGHT: PRESCRIPTION ANTIHYPERLIPIDEMIC DRUGS

• Table 8-1: Marketed Antihyperlipidemic Drugs
• Table 8-2: Total World Prescription Antihyperlipidemic Drugs Market 2004-2011
• Figure 8-1: Total World Prescription Antihyperlipidemic Drugs Market 2004-2011
• Table 8-3: Antihyperlipidemic Drugs in Development
• Table 8-4: Total Global Market for Prescription Antihyperlipidemic Drugs Revenues and Market Share by Supplier 2006
• Figure 8-2: Total Global Market for Prescription Antihyperlipidemic Drugs Market Share by Leading Supplier 2006

CHAPTER NINE: PRESCRIPTION BLOOD MODIFIER DRUGS

• Table 9-2: Marketed Anticoagulant Drugs
• Table 9-3: Marketed Antiplatelet Drugs
• Table 9-4: Marketed Thrombolytic Drugs
• Table 9-5: Total World Prescription Blood Modifier Drug Market 2004-2011
• Figure 9-1: Total World Prescription Blood Modifier Drug Market 2004-2011
• Table 9-6: The Global Market for Prescription Blood Modifier Drugs by Type 2004-2011
• Figure 9-2: Global Market for Prescription Blood Modifier Drugs by Type 2006
• Table 9-7: Blood Modifier Drugs in Development
• Table 9-8: Total Global Market for Prescription Blood Modifiers, Revenues and Market Share by Supplier 2006
• Figure 9-4: Total Global Market for Prescription Blood Modifier Drugs, Market Share by Leading Supplier 2006

CHAPTER TEN: PRESCRIPTION DIURETIC DRUGS

• Table 10-1: Marketed Diurectic Drugs
• Table 10-2: Total World Prescription Diuretic Drugs Market 2004-2011
• Figure 10-1: Total World Prescription Diuretic Drugs Market 2004-2011
• Table 10-3: Diuretic Drugs in Development
• Table 10-4: Total Global Market for Prescription Diuretic Drugs, Revenues and Market Share by Supplier 2006
• Figure 10-2: Total Global Market for Prescription Diuretic Drugs, Market Share by Leading Supplier 2006

CHAPTER ELEVEN: PRESCRIPTION OTHER CARDIOVASCULAR DRUGS

• Table 11-1: Marketed Other Cardiovascular Drugs
• Table 11-2: Total World Other Cardiovascular Drug Market 2004-2011
• Figure 11-1: Total World Other Cardiovascular Drug Market 2004-2011
• Table 11-3: Other Cardiovascular Drugs in Development
• Table 11-4: Total World Market for Other Cardiovascular Drugs Revenues and Market Share by Supplier 2006
• Figure 11-5: Total World Market for Other Cardiovascular Drugs Market Share by Leading Supplier 2006

CHAPTER TWELVE: WORLD MARKET SUMMARY

• Table 12-1: Total World Prescription Cardiovascular Drug Market 2004-2011
• Table 12-2 Total World Prescription Cardiovascular Drug Market by Product Segment 2004-2011
• Figure 12-1: Total World Prescription Cardiovascular Drug Market by Product Segment 2004-2011
• Figure 12-2: The World Market for Prescription Cardiovascular Drugs by Product Segment Market Share 2006
• Table 12-3: World Market for Prescription Cardiovascular Drugs Revenues and Segments of Participation by Major Areas of Participation 2006
• Figure 12-3: World Market for Prescription Cardiovascular Drugs Revenues and Segments of Participation by Major Areas of Participation 2006